IP Library › Granted Patent US 8,207,129
Granted Patent B2
US 8,207,129 · App. 12/497,886 · Granted Jun 26, 2012

Treatment with cyclosporin A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,207,129
App. No.
12/497,886
Granted
Jun 26, 2012
Kind
B2
Abstract

Disclosed herein is a method comprising administering cyclosporin A topically to an eye of a person for the purpose of treating or preventing loss of vision from keratoconus.

Claims (6)

1. A method of treating impaired vision due to keratoconus, the method comprising topically administering to an eye of person having such impaired vision a composition comprising cyclosporin A.

2. The method of claim 1 , wherein the composition comprises about 0.005% to about 0.15% cyclosporin A by weight.

3. The method of claim 1 , wherein the composition comprises 0.005% to 0.15% cyclosporin A by weight.

4. The method of claim 3 , wherein the composition comprises 0.005% cyclosporin A by weight.

5. The method of claim 3 , wherein the composition comprises 0.02% cyclosporin A by weight.

6. The method of claim 3 , wherein the composition comprises 0.05% cyclosporin A by weight.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2017
From: ALLERGAN, INC.
To: SAINT REGIS MOHAWK TRIBE
Reel/Frame 043830/0446 →